Investment Stage

Focus Areas

About Investor

Peter Crane is a Partner at Lunar Ventures (Bio), focusing on investments in material science, medical devices, pharmaceuticals, biotech, AI, diagnostics, deep tech, therapeutics, and digital health companies from pre-seed through seed stages, with investment ranges typically between $301K and $1.0M. As Co-Founder and CEO of Caeruleus Genomics and Entelo Bio, both Oxford-based biotech startups, Peter has extensive experience in the biotechnology industry. He previously served as Vice President of Strategy at Infinitopes and Principal at Outsized Ventures, with experience in business development and corporate strategy at Synthace and Luminous Ventures. He holds a DPhil (PhD) in Chemical Biology from the University of Oxford and an MSc in Chemistry from the University of Warwick.